OriGen Biomedical, Inc.
Ex parte reexamination requester·3 ex parte reexams
OriGen Biomedical, Inc. has requested 3 USPTO ex parte reexaminations. It most often challenges patents owned by New York Blood Center, Inc. and Cesca Therapeutics Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners challenged
Outcome track record
How this requester's challenges resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Share of challenges that canceled claims
Challenge metrics
Cancellation rate, average pendency, and the open/closed split across every reexam this requester has filed.
- Outcome rate of closed challenges
- Average pendency in months
Examiners & defense counsel
Which examiners decide this requester's challenges, and which firms defend the targeted patents.
- Most frequent examiners
- Top opposing counsel
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/013,325 | Sep 25, 2014 | 6,232,115 | Freezing and Thawing Bag, Mold, Apparatus and Method | Cesca Therapeutics Inc. | Closed |
| 90/013,321 | Aug 21, 2014 | 6,491,678 | Freezer Bag | New York Blood Center, Inc. | Closed |
| 90/013,178 | Mar 11, 2014 | 6,491,678 | Freezer Bag | New York Blood Center, Inc. | Closed |
See the full reexam picture for OriGen Biomedical, Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.